3/8/12
Agere aquires additional manufacturing capabilities
Agere has aquired a Capsugel Ultra 8 II capsule filler and a Patterson-Kelley 5 cu.ft. double-cone vacuum tumble dryer. This equipment will be used to support cGMP manufacturing operations.
Latest News
1/26/12
Agere presents at Enhancing Drug Bioavailability and Solubility conference
Dr. Jeff Gautschi presented "Solid Dispersion Formulations to Enhance Oral Bioavailability: Concept-to-Clinic Approaches" at the Enhancing Drug Bioavailability and Solubility conference on January 25, 2012.
1/16/12
Agere aquires Korsch XL100 tablet press
Agere aquires a Korsch XL100 tablet press to support cGMP manufacturing operations.
11/29/11
Agere presents at Harvard University
Dr. Dan Smithey presented "Fundamental and Practical Aspects for Delivery of Insoluble Compounds: Emphasis on Amorphous Solid Dispersions," at "Nano Meets Pharma" symposium and Harvard University on November 29, 2011.
7/29/11
Thermo Fisher, Agere announce collaboration to offer GMP Hot Melt Extrusion
Thermo Fisher and Agere have announced today they will make available their combined expertise and capabilities to benefit companies working on formulation using twin-screw melt extrusion for melt granulation and solid dispersions of poorly soluble compounds. The offering will accelerate formulation development and strive to reduce time and cost to FIH proof of concept studies. Thermo Fisher will install its state-of-the-art Pharma 16 Hot Melt Extruder at Agere's GMP facility located in Bend, OR. Agere will utilize its in-depth knowledge of solid dispersions and HME to develop improved formulations. Agere will evaluate the formulations using its novel testing methodologies to rank order formulations with respect to anticipated bioavailability. This offering will allow customers a single site to have process/formulation development, scale-up and GMP manufacturing. Read Press Release
7/15/11
Agere expands cGMP capabilities through acquisition of Anhydro MS 150 Spray Drier
Agere acquires an Anhydro MS 150 spray drier for installation in the state-of-the-art cGMP facility, offering cGMP manufacturing of clinical trial material. Agere's expertise in spray dried dispersions affords a scalable process from the development stage to the manufacturing stage on the Anhydro MS 150.
7/15/11
Agere to attend American Association of Pharmaceutical Scientists conference
Agere will be attending the 25th annual American Association of Pharmaceutical Scientists (AAPS) meeting and exposition on October 23 – 27, 2011 in Washington, DC. Please stop by to discuss how Agere's rapidly expanding portfolio of manufacturing, formulation and analytical capabilities can be utilized to accelerate your path to market.
6/15/11
Mr. Ryan Minikis joins Agere team as QC Director
Agere is pleased to announce that Mr. Ryan Minikis has joined the Agere team as Quality Control Director. Mr. Minikis will be responsible for analytical method development and validation efforts as well as comprehensive QC laboratory operations including cleaning verification, raw material and finished product testing, and ICH stability programs. Mr. Minikis has over 10 years of experience in roles ranging from formulation development to GLP and GMP laboratory operations. Mr. Minikis has extensive knowledge of solid dispersion development and technical transfer to the cGMP manufacturing environment.
6/15/11
Agere to attend Controlled Release Society conference
Agere will be attending the 38th annual meeting and exposition of the Controlled Release Society (CRS) on July 30 – August 3, 2011 in National Harbor, MD. Stop by booth 702 to learn more about our Agere's current and future cGMP capabilities.
10/22/10
Agere Expands into New Facility
Agere has moved into a new state-of-the-art 10,000 sq. ft. facility in order to provide cGMP manufacturing of formulations and to expand analytical services. The new facility will eventually provided spray drying, solid dosage form, and parenteral development and manufacturing.